2Y01 - Header Asymmetric Unit

HEADER RECEPTOR 30-NOV-10 2Y01

TITLE TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS TITLE 2 AND BOUND PARTIAL AGONIST DOBUTAMINE (CRYSTAL DOB102)

COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-1 ADRENERGIC RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 33-368; COMPND 5 SYNONYM: BETA-1 ADRENORECEPTOR, BETA-1 ADRENOCEPTOR, BETA-T; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: RESIDUES 3-32 AT THE N-TERMINUS AND RESIDUES 244-271 COMPND 9 OF THE THIRD INTRACELLULAR LOOP WERE DELETED FROM THE CONSTRUCT. COMPND 10 THE CONSTRUCT WAS TRUNCATED AFTER RESIDUE 367 AND A HEXAHIS TAG COMPND 11 ADDED.

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MELEAGRIS GALLOPAVO; SOURCE 3 ORGANISM_COMMON: TURKEY; SOURCE 4 ORGANISM_TAXID: 9103; SOURCE 5 CELL: ERYTHROCYTE; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PBACPAK8

KEYWDS RECEPTOR, G PROTEIN COUPLED RECEPTOR, SEVEN-HELIX RECEPTOR, INTEGRAL KEYWDS 2 MEMBRANE PROTEIN, THERMOSTABILISING POINT MUTATIONS, GPCR, 7TM KEYWDS 3 RECEPTOR

EXPDTA X-RAY DIFFRACTION

AUTHOR A.WARNE,R.MOUKHAMETZIANOV,J.G.BAKER,R.NEHME,P.C.EDWARDS,A.G.W.LESLIE, AUTHOR 2 G.F.X.SCHERTLER,C.G.TATE

REVDAT 3 17-AUG-11 2Y01 1 REMARK HETATM VERSN REVDAT 2 30-MAR-11 2Y01 1 REVDAT JRNL REVDAT 1 30-MAR-11 2Y01 0

JRNL AUTH A.WARNE,R.MOUKHAMETZIANOV,J.G.BAKER,R.NEHME,P.C.EDWARDS, JRNL AUTH 2 A.G.W.LESLIE,G.F.X.SCHERTLER,C.G.TATE JRNL TITL THE STRUCTURAL BASIS FOR AGONIST AND PARTIAL AGONIST ACTION JRNL TITL 2 ON A BETA1-ADRENERGIC RECEPTOR JRNL REF NATURE V. 469 241 2011 JRNL REFN ISSN 0028-0836 JRNL PMID 21228877 JRNL DOI 10.1038/NATURE09746

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.J.SERRANO-VEGA,F.MAGNANI,Y.SHIBATA,C.G.TATE REMARK 1 TITL CONFORMATIONAL THERMOSTABILIZATION OF THE BETA1- ADRENERGIC REMARK 1 TITL 2 RECEPTOR IN A DETERGENT-RESISTANT FORM. REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 105 877 2008 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 18192400 REMARK 1 DOI 10.1073/PNAS.0711253105 REMARK 1 REFERENCE 2 REMARK 1 AUTH T.WARNE,M.J.SERRANO-VEGA,J.G.BAKER,R.MOUKHAMETZIANOV, REMARK 1 AUTH 2 P.C.EDWARDS,R.HENDERSON,A.G.W.LESLIE,C.G.TATE, REMARK 1 AUTH 3 G.F.X.SCHERTLER REMARK 1 TITL STRUCTURE OF A BETA1-ADRENERGIC G-PROTEIN-COUPLED RECEPTOR. REMARK 1 REF NATURE V. 454 486 2008 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 18594507 REMARK 1 DOI 10.1038/NATURE07101

REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 95.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 94.62 REMARK 3 NUMBER OF REFLECTIONS : 29388 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.22772 REMARK 3 R VALUE (WORKING SET) : 0.22571 REMARK 3 FREE R VALUE : 0.26636 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 1565 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.600 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.668 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1954 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.26 REMARK 3 BIN R VALUE (WORKING SET) : 0.309 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.334 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4639 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 373 REMARK 3 SOLVENT ATOMS : 41 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.0 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.484 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.36 REMARK 3 B22 (A**2) : 0.52 REMARK 3 B33 (A**2) : -1.44 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.69 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.451 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.298 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.213 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.967 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5129 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6968 ; 1.385 ; 2.016 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 581 ; 4.995 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 178 ;34.427 ;22.022 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 808 ;18.030 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 35 ;15.532 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 832 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3577 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2915 ; 1.455 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4733 ; 2.783 ; 5.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2214 ; 3.569 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2235 ; 5.756 ;10.000 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 10 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 47 A 65 1 REMARK 3 1 B 47 B 65 1 REMARK 3 2 A 75 A 97 1 REMARK 3 2 B 75 B 97 1 REMARK 3 3 A 111 A 143 1 REMARK 3 3 B 111 B 143 1 REMARK 3 4 A 153 A 176 1 REMARK 3 4 B 153 B 176 1 REMARK 3 5 A 205 A 219 1 REMARK 3 5 B 205 B 219 1 REMARK 3 6 A 222 A 226 1 REMARK 3 6 B 222 B 226 1 REMARK 3 7 A 279 A 303 1 REMARK 3 7 B 279 B 303 1 REMARK 3 8 A 331 A 358 1 REMARK 3 8 B 331 B 358 1 REMARK 3 9 A 33 A 46 4 REMARK 3 9 B 33 B 46 4 REMARK 3 10 A 98 A 110 4 REMARK 3 10 B 98 B 110 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1326 ; 0.04 ; 0.05 REMARK 3 TIGHT POSITIONAL 1 B (A): 1326 ; 0.04 ; 0.05 REMARK 3 MEDIUM POSITIONAL 1 A (A): 208 ; 0.06 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 B (A): 208 ; 0.06 ; 0.50 REMARK 3 TIGHT THERMAL 1 A (A**2): 1326 ; 3.34 ; 10.00 REMARK 3 TIGHT THERMAL 1 B (A**2): 1326 ; 3.34 ; 10.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 208 ; 2.41 ; 20.00 REMARK 3 MEDIUM THERMAL 1 B (A**2): 208 ; 2.41 ; 20.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS.

REMARK 4 REMARK 4 2Y01 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-DEC-10. REMARK 100 THE PDBE ID CODE IS EBI-46474.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD (MX-225) REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30953 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.60 REMARK 200 RESOLUTION RANGE LOW (A) : 49.90 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 3.8 REMARK 200 R MERGE (I) : 0.13 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.10 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.8 REMARK 200 R MERGE FOR SHELL (I) : 0.72 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2VT4 REMARK 200 REMARK 200 REMARK: NONE

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROP VAPOUR DIFFUSION, REMARK 280 PROTEIN (15MG/ML) IN 100MM NACL, 0.1MM EDTA, 1.0MM (R, REMARK 280 S)-DOBUTAMINE, 0.9MG/ML CHS, 0.6% HEGA-10, 0.1M BICINE PH9, REMARK 280 25% PEG600 AT 4 DEGREES C

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.80000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ARG 68 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN A, MET 90 TO VAL REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 116 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, TYR 227 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ALA 282 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 327 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 338 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 358 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ARG 68 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, MET 90 TO VAL REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 116 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, TYR 227 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ALA 282 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PHE 327 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PHE 338 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 358 TO ALA

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 31 REMARK 465 GLY A 32 REMARK 465 LYS A 240 REMARK 465 ILE A 241 REMARK 465 ASP A 242 REMARK 465 ARG A 243 REMARK 465 ALA A 272 REMARK 465 SER A 273 REMARK 465 LYS A 274 REMARK 465 ARG A 275 REMARK 465 LYS A 276 REMARK 465 THR A 277 REMARK 465 PHE A 359 REMARK 465 PRO A 360 REMARK 465 ARG A 361 REMARK 465 LYS A 362 REMARK 465 ALA A 363 REMARK 465 ASP A 364 REMARK 465 ARG A 365 REMARK 465 ARG A 366 REMARK 465 LEU A 367 REMARK 465 HIS A 368 REMARK 465 HIS A 369 REMARK 465 HIS A 370 REMARK 465 HIS A 371 REMARK 465 HIS A 372 REMARK 465 HIS A 373 REMARK 465 MET B 31 REMARK 465 GLY B 32 REMARK 465 PHE B 359 REMARK 465 PRO B 360 REMARK 465 ARG B 361 REMARK 465 LYS B 362 REMARK 465 ALA B 363 REMARK 465 ASP B 364 REMARK 465 ARG B 365 REMARK 465 ARG B 366 REMARK 465 LEU B 367 REMARK 465 HIS B 368 REMARK 465 HIS B 369 REMARK 465 HIS B 370 REMARK 465 HIS B 371 REMARK 465 HIS B 372 REMARK 465 HIS B 373

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 83 CD1

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 73 30.74 -91.88 REMARK 500 GLN A 194 50.29 -100.07 REMARK 500 ASP A 195 106.53 -160.30 REMARK 500 PHE A 201 74.23 -101.82 REMARK 500 PHE A 216 -63.68 -128.28 REMARK 500 GLU A 236 42.94 -74.92 REMARK 500 ARG A 279 -35.83 -38.27 REMARK 500 ASN A 316 104.47 -162.49 REMARK 500 SER B 145 62.09 -168.06 REMARK 500 PHE B 216 -60.22 -126.64 REMARK 500 LYS B 240 -3.53 74.67 REMARK 500 SER B 273 -6.93 -59.70 REMARK 500 THR B 277 -51.07 -131.56 REMARK 500 REMARK 500 REMARK: NULL

REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 2CV A 502 REMARK 610 2CV A 503 REMARK 610 2CV B 501 REMARK 610 2CV B 502 REMARK 610 2CV B 503 REMARK 610 2CV B 504

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Y01 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Y01 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Y00 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Y01 B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Y01 B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CV B 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Y00 B 601

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DEP RELATED DB: PDB REMARK 900 MEMBRANE PROTEIN, NMR, 1 STRUCTURE REMARK 900 RELATED ID: 2VT4 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH REMARK 900 STABILISING MUTATIONS AND BOUND CYANOPINDOLOL REMARK 900 RELATED ID: 2Y04 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH REMARK 900 STABILISING MUTATIONS AND BOUND PARTIAL REMARK 900 AGONIST SALBUTAMOL REMARK 900 RELATED ID: 2Y00 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH REMARK 900 STABILISING MUTATIONS AND BOUND PARTIAL REMARK 900 AGONIST DOBUTAMINE (CRYSTAL DOB92) REMARK 900 RELATED ID: 2Y03 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH REMARK 900 STABILISING MUTATIONS AND BOUND AGONIST REMARK 900 ISOPRENALINE REMARK 900 RELATED ID: 2Y02 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH REMARK 900 STABILISING MUTATIONS AND BOUND AGONIST REMARK 900 CARMOTEROL

REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FOLLOWING MUTATIONS WERE MADE TO IMPROVE REMARK 999 THERMOSTABILITY R68S,M90V,Y227A,A282L,F327A,F338M THE REMARK 999 FOLLOWING MUTATIONS WERE MADE TO IMPROVE EXPRESSION AND REMARK 999 HELP CRYSTALLISATION C116L, C358A

DBREF 2Y01 A 33 368 UNP P07700 ADRB1_MELGA 33 368 DBREF 2Y01 B 33 368 UNP P07700 ADRB1_MELGA 33 368

SEQADV 2Y01 MET A 31 UNP P07700 EXPRESSION TAG SEQADV 2Y01 GLY A 32 UNP P07700 EXPRESSION TAG SEQADV 2Y01 SER A 68 UNP P07700 ARG 68 ENGINEERED MUTATION SEQADV 2Y01 VAL A 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 2Y01 LEU A 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 2Y01 ALA A 227 UNP P07700 TYR 227 ENGINEERED MUTATION SEQADV 2Y01 A UNP P07700 CYS 244 DELETION SEQADV 2Y01 A UNP P07700 GLU 245 DELETION SEQADV 2Y01 A UNP P07700 GLY 246 DELETION SEQADV 2Y01 A UNP P07700 ARG 247 DELETION SEQADV 2Y01 A UNP P07700 PHE 248 DELETION SEQADV 2Y01 A UNP P07700 TYR 249 DELETION SEQADV 2Y01 A UNP P07700 GLY 250 DELETION SEQADV 2Y01 A UNP P07700 SER 251 DELETION SEQADV 2Y01 A UNP P07700 GLN 252 DELETION SEQADV 2Y01 A UNP P07700 GLU 253 DELETION SEQADV 2Y01 A UNP P07700 GLN 254 DELETION SEQADV 2Y01 A UNP P07700 PRO 255 DELETION SEQADV 2Y01 A UNP P07700 GLN 256 DELETION SEQADV 2Y01 A UNP P07700 PRO 257 DELETION SEQADV 2Y01 A UNP P07700 PRO 258 DELETION SEQADV 2Y01 A UNP P07700 PRO 259 DELETION SEQADV 2Y01 A UNP P07700 LEU 260 DELETION SEQADV 2Y01 A UNP P07700 PRO 261 DELETION SEQADV 2Y01 A UNP P07700 GLN 262 DELETION SEQADV 2Y01 A UNP P07700 HIS 263 DELETION SEQADV 2Y01 A UNP P07700 GLN 264 DELETION SEQADV 2Y01 A UNP P07700 PRO 265 DELETION SEQADV 2Y01 A UNP P07700 ILE 266 DELETION SEQADV 2Y01 A UNP P07700 LEU 267 DELETION SEQADV 2Y01 A UNP P07700 GLY 268 DELETION SEQADV 2Y01 A UNP P07700 ASN 269 DELETION SEQADV 2Y01 A UNP P07700 GLY 270 DELETION SEQADV 2Y01 A UNP P07700 ARG 271 DELETION SEQADV 2Y01 HIS A 369 UNP P07700 EXPRESSION TAG SEQADV 2Y01 HIS A 370 UNP P07700 EXPRESSION TAG SEQADV 2Y01 HIS A 371 UNP P07700 EXPRESSION TAG SEQADV 2Y01 HIS A 372 UNP P07700 EXPRESSION TAG SEQADV 2Y01 HIS A 373 UNP P07700 EXPRESSION TAG SEQADV 2Y01 LEU A 282 UNP P07700 ALA 282 ENGINEERED MUTATION SEQADV 2Y01 ALA A 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 2Y01 MET A 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 2Y01 ALA A 358 UNP P07700 CYS 358 ENGINEERED MUTATION SEQADV 2Y01 MET B 31 UNP P07700 EXPRESSION TAG SEQADV 2Y01 GLY B 32 UNP P07700 EXPRESSION TAG SEQADV 2Y01 SER B 68 UNP P07700 ARG 68 ENGINEERED MUTATION SEQADV 2Y01 VAL B 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 2Y01 LEU B 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 2Y01 ALA B 227 UNP P07700 TYR 227 ENGINEERED MUTATION SEQADV 2Y01 B UNP P07700 CYS 244 DELETION SEQADV 2Y01 B UNP P07700 GLU 245 DELETION SEQADV 2Y01 B UNP P07700 GLY 246 DELETION SEQADV 2Y01 B UNP P07700 ARG 247 DELETION SEQADV 2Y01 B UNP P07700 PHE 248 DELETION SEQADV 2Y01 B UNP P07700 TYR 249 DELETION SEQADV 2Y01 B UNP P07700 GLY 250 DELETION SEQADV 2Y01 B UNP P07700 SER 251 DELETION SEQADV 2Y01 B UNP P07700 GLN 252 DELETION SEQADV 2Y01 B UNP P07700 GLU 253 DELETION SEQADV 2Y01 B UNP P07700 GLN 254 DELETION SEQADV 2Y01 B UNP P07700 PRO 255 DELETION SEQADV 2Y01 B UNP P07700 GLN 256 DELETION SEQADV 2Y01 B UNP P07700 PRO 257 DELETION SEQADV 2Y01 B UNP P07700 PRO 258 DELETION SEQADV 2Y01 B UNP P07700 PRO 259 DELETION SEQADV 2Y01 B UNP P07700 LEU 260 DELETION SEQADV 2Y01 B UNP P07700 PRO 261 DELETION SEQADV 2Y01 B UNP P07700 GLN 262 DELETION SEQADV 2Y01 B UNP P07700 HIS 263 DELETION SEQADV 2Y01 B UNP P07700 GLN 264 DELETION SEQADV 2Y01 B UNP P07700 PRO 265 DELETION SEQADV 2Y01 B UNP P07700 ILE 266 DELETION SEQADV 2Y01 B UNP P07700 LEU 267 DELETION SEQADV 2Y01 B UNP P07700 GLY 268 DELETION SEQADV 2Y01 B UNP P07700 ASN 269 DELETION SEQADV 2Y01 B UNP P07700 GLY 270 DELETION SEQADV 2Y01 B UNP P07700 ARG 271 DELETION SEQADV 2Y01 LEU B 282 UNP P07700 ALA 282 ENGINEERED MUTATION SEQADV 2Y01 ALA B 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 2Y01 MET B 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 2Y01 ALA B 358 UNP P07700 CYS 358 ENGINEERED MUTATION SEQADV 2Y01 HIS B 369 UNP P07700 EXPRESSION TAG SEQADV 2Y01 HIS B 370 UNP P07700 EXPRESSION TAG SEQADV 2Y01 HIS B 371 UNP P07700 EXPRESSION TAG SEQADV 2Y01 HIS B 372 UNP P07700 EXPRESSION TAG SEQADV 2Y01 HIS B 373 UNP P07700 EXPRESSION TAG

SEQRES 1 A 315 MET GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY SEQRES 2 A 315 MET SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL SEQRES 3 A 315 ALA GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY SER THR SEQRES 4 A 315 GLN ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER SEQRES 5 A 315 LEU ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL SEQRES 6 A 315 PRO PHE GLY ALA THR LEU VAL VAL ARG GLY THR TRP LEU SEQRES 7 A 315 TRP GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP SEQRES 8 A 315 VAL LEU CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL SEQRES 9 A 315 ILE ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE SEQRES 10 A 315 ARG TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL SEQRES 11 A 315 ILE ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER SEQRES 12 A 315 PHE LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP SEQRES 13 A 315 PRO GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS SEQRES 14 A 315 ASP PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER SEQRES 15 A 315 ILE ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE SEQRES 16 A 315 VAL ALA LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE SEQRES 17 A 315 ARG LYS ILE ASP ARG ALA SER LYS ARG LYS THR SER ARG SEQRES 18 A 315 VAL MET LEU MET ARG GLU HIS LYS ALA LEU LYS THR LEU SEQRES 19 A 315 GLY ILE ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO SEQRES 20 A 315 PHE PHE LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP SEQRES 21 A 315 LEU VAL PRO ASP TRP LEU PHE VAL ALA PHE ASN TRP LEU SEQRES 22 A 315 GLY TYR ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS SEQRES 23 A 315 ARG SER PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU SEQRES 24 A 315 ALA PHE PRO ARG LYS ALA ASP ARG ARG LEU HIS HIS HIS SEQRES 25 A 315 HIS HIS HIS SEQRES 1 B 315 MET GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY SEQRES 2 B 315 MET SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL SEQRES 3 B 315 ALA GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY SER THR SEQRES 4 B 315 GLN ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER SEQRES 5 B 315 LEU ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL SEQRES 6 B 315 PRO PHE GLY ALA THR LEU VAL VAL ARG GLY THR TRP LEU SEQRES 7 B 315 TRP GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP SEQRES 8 B 315 VAL LEU CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL SEQRES 9 B 315 ILE ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE SEQRES 10 B 315 ARG TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL SEQRES 11 B 315 ILE ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER SEQRES 12 B 315 PHE LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP SEQRES 13 B 315 PRO GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS SEQRES 14 B 315 ASP PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER SEQRES 15 B 315 ILE ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE SEQRES 16 B 315 VAL ALA LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE SEQRES 17 B 315 ARG LYS ILE ASP ARG ALA SER LYS ARG LYS THR SER ARG SEQRES 18 B 315 VAL MET LEU MET ARG GLU HIS LYS ALA LEU LYS THR LEU SEQRES 19 B 315 GLY ILE ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO SEQRES 20 B 315 PHE PHE LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP SEQRES 21 B 315 LEU VAL PRO ASP TRP LEU PHE VAL ALA PHE ASN TRP LEU SEQRES 22 B 315 GLY TYR ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS SEQRES 23 B 315 ARG SER PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU SEQRES 24 B 315 ALA PHE PRO ARG LYS ALA ASP ARG ARG LEU HIS HIS HIS SEQRES 25 B 315 HIS HIS HIS

HET Y01 A 401 35 HET Y01 A 402 35 HET 2CV A 501 26 HET 2CV A 502 5 HET 2CV A 503 20 HET 2CV A 504 26 HET 2CV A 505 26 HET Y00 A 601 22 HET Y01 B 401 35 HET Y01 B 402 35 HET 2CV B 501 20 HET 2CV B 502 16 HET 2CV B 503 16 HET 2CV B 504 8 HET 2CV B 505 26 HET Y00 B 601 22

HETNAM 2CV HEGA-10 HETNAM Y01 CHOLESTEROL HEMISUCCINATE HETNAM Y00 DOBUTAMINE

FORMUL 3 2CV 10(C18 H37 N O7) FORMUL 4 Y01 4(C31 H50 O4) FORMUL 5 Y00 2(C18 H23 N O3) FORMUL 6 HOH *41(H2 O)

HELIX 1 1 ALA A 33 SER A 68 1 36 HELIX 2 2 THR A 69 GLN A 73 5 5 HELIX 3 3 LEU A 75 LEU A 93 1 19 HELIX 4 4 LEU A 93 GLY A 105 1 13 HELIX 5 5 GLY A 110 SER A 145 1 36 HELIX 6 6 SER A 145 MET A 153 1 9 HELIX 7 7 THR A 154 MET A 179 1 26 HELIX 8 8 ASP A 186 GLN A 194 1 9 HELIX 9 9 ASN A 204 PHE A 216 1 13 HELIX 10 10 PHE A 216 GLU A 236 1 21 HELIX 11 11 SER A 278 ASN A 316 1 39 HELIX 12 12 PRO A 321 ASN A 335 1 15 HELIX 13 13 ALA A 337 TYR A 343 1 7 HELIX 14 14 SER A 346 LEU A 357 1 12 HELIX 15 15 ALA B 33 THR B 69 1 37 HELIX 16 16 GLN B 70 GLN B 73 5 4 HELIX 17 17 LEU B 75 LEU B 93 1 19 HELIX 18 18 LEU B 93 GLY B 105 1 13 HELIX 19 19 GLY B 110 SER B 145 1 36 HELIX 20 20 PHE B 147 MET B 153 1 7 HELIX 21 21 THR B 154 MET B 179 1 26 HELIX 22 22 ASP B 186 ASP B 195 1 10 HELIX 23 23 ASN B 204 PHE B 216 1 13 HELIX 24 24 PHE B 216 ILE B 238 1 23 HELIX 25 25 THR B 277 ASN B 316 1 40 HELIX 26 26 PRO B 321 ASN B 335 1 15 HELIX 27 27 ALA B 337 TYR B 343 1 7 HELIX 28 28 SER B 346 LEU B 357 1 12

SSBOND 1 CYS A 114 CYS A 199 1555 1555 2.04 SSBOND 2 CYS A 192 CYS A 198 1555 1555 2.06 SSBOND 3 CYS B 114 CYS B 199 1555 1555 2.05 SSBOND 4 CYS B 192 CYS B 198 1555 1555 2.08

SITE 1 AC1 6 ARG A 157 ILE A 161 HOH A2019 ARG B 205 SITE 2 AC1 6 ALA B 206 2CV B 501 SITE 1 AC2 3 GLY A 67 LEU A 78 TRP A 166 SITE 1 AC3 10 HIS A 180 TRP A 181 ARG A 183 ASP A 184 SITE 2 AC3 10 ASN A 204 HOH A2020 VAL B 160 THR B 164 SITE 3 AC3 10 Y01 B 401 2CV B 505 SITE 1 AC4 1 LEU A 289 SITE 1 AC5 6 ARG A 205 VAL A 314 PHE A 315 LEU B 152 SITE 2 AC5 6 ARG B 157 Y01 B 401 SITE 1 AC6 4 VAL A 51 VAL A 326 MET A 338 Y00 A 601 SITE 1 AC7 5 LYS A 159 VAL A 160 CYS A 163 GLU B 185 SITE 2 AC7 5 2CV B 501 SITE 1 AC8 9 ASP A 121 SER A 211 PHE A 306 PHE A 307 SITE 2 AC8 9 ASN A 310 ASN A 329 TRP A 330 TYR A 333 SITE 3 AC8 9 2CV A 504 SITE 1 AC9 8 ALA A 206 2CV A 501 2CV A 503 HOH A2020 SITE 2 AC9 8 CYS B 133 ARG B 157 VAL B 160 ILE B 214 SITE 1 BC1 3 LEU B 78 LYS B 159 TRP B 166 SITE 1 BC2 8 VAL A 160 THR A 164 Y01 A 401 2CV A 505 SITE 2 BC2 8 PRO B 176 TRP B 181 ASP B 184 GLU B 185 SITE 1 BC3 4 TYR B 231 HIS B 286 LEU B 289 GLY B 293 SITE 1 BC4 2 ARG A 157 PHE B 315 SITE 1 BC5 2 MET B 48 TRP B 330 SITE 1 BC6 6 GLU A 185 2CV A 501 LYS B 159 VAL B 160 SITE 2 BC6 6 CYS B 163 TRP B 166 SITE 1 BC7 11 VAL B 102 TRP B 117 THR B 118 ASP B 121 SITE 2 BC7 11 PHE B 201 SER B 211 ASN B 310 ASN B 329 SITE 3 BC7 11 TRP B 330 TYR B 333 HOH B2021

CRYST1 90.100 61.600 101.400 90.00 108.90 90.00 P 1 21 1 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.011099 0.000000 0.003800 0.00000

SCALE2 0.000000 0.016234 0.000000 0.00000

SCALE3 0.000000 0.000000 0.010424 0.00000